Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Hydrocortisone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 3/20 | 0.83 |
| ▸ | HIF1A | Q16665 | 11/20 | 0.83 |
| ▸ | NR3C2 | P08235 | 5/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.83 |
| ▸ | PGR | P06401 | 3/20 | 0.83 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.83 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.83 |
| ▸ | MAPT | P10636 | 2/20 | 0.83 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.83 |
| ▸ | SHBG | P04278 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | AR | P10275 | 1/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrocortisone SCHEMBL122188 | 1.00 | HIF1A (0.83) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL4697 | 0.98 | HIF1A (0.86) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL28908729 | 0.98 | HIF1A (0.86) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL27961626 | 0.97 | HIF1A (0.85) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL27804799 | 0.97 | HIF1A (0.83) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL28435897 | 0.96 | HIF1A (0.82) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL29263567 | 0.96 | HIF1A (0.82) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL4278629 | 0.96 | HIF1A (0.91) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL180227 | 0.96 | HIF1A (0.91) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 | |
| Hydrocortisone SCHEMBL26659908 | 0.95 | HIF1A (0.89) | HIF1ANR3C2SMN1; SMN2NR3C1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9314357-B2 | Stent for placement in living body and stent delivery system | TERUMO KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| EP-2444033-B1 | STENT FOR PLACEMENT IN LIVING BODY, AND STENT DELIVERY SYSTEM | TERUMO CORP (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-8518102-B2 | Stent for placement in living body, and stent delivery system | TERUMO KABUSHIKI KAISHA (JP) | 2013-08-27 | — | — | US | disclosed |
| EP-2322121-B1 | STENT FOR PLACEMENT IN LIVING BODY, AND STENT DELIVERY SYSTEM | TERUMO CORP (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20120158119-A1 | STENT FOR PLACEMENT IN LIVING BODY AND STENT DELIVERY SYSTEM | TERUMO KABUSHIKI KAISHA (JP) | 2012-06-21 | — | — | US | disclosed |
| EP-2444033-A1 | STENT FOR PLACEMENT IN LIVING BODY, AND STENT DELIVERY SYSTEM | Terumo Kabushiki Kaisha (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20110196475-A1 | STENT FOR PLACEMENT IN LIVING BODY, AND STENT DELIVERY SYSTEM | TERUMO KABUSHIKI KAISHA (JP) | 2011-08-11 | — | — | US | disclosed |
| EP-2322121-A1 | STENT FOR PLACEMENT IN LIVING BODY, AND STENT DELIVERY SYSTEM | Terumo Kabushiki Kaisha (JP) | 2011-05-18 | — | — | EP | disclosed |